Quick Answer
STAAR SURGICAL CO reported Cash and Equivalents of $153.15 million for fiscal year 2025.
STAAR SURGICAL CO Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $153.15M | +6.2% |
| 2024 | $144.16M | -21.2% |
| 2023 | $183.04M | +111.7% |
| 2022 | $86.48M | -56.7% |
| 2021 | $199.71M | +31.0% |
| 2020 | $152.45M | +27.1% |
| 2019 | $119.97M | +15.5% |
| 2018 | $103.88M | +460.9% |
| 2017 | $18.52M | +32.3% |
| 2016 | $14.00M | +4.5% |
| 2015 | $13.40M | +3.0% |
| 2014 | $13.01M | -43.3% |
| 2013 | $22.95M | +5.9% |
| 2012 | $21.68M | +30.7% |
| 2011 | $16.58M | +76.9% |
| 2010 | $9.38M | +48.1% |
| 2009 | $6.33M | +26.8% |
| 2008 | $4.99M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $176.16M | +7.4% | +5.4% |
| June 30, 2025 | $167.13M | -13.3% | -3.5% |
| March 31, 2025 | $173.11M | -22.7% | +20.1% |
| December 31, 2024 | $144.16M | -21.2% | -12.1% |
| September 30, 2024 | $164.00M | +28.7% | -14.9% |
| June 30, 2024 | $192.78M | +103.6% | -13.9% |
| March 31, 2024 | $224.02M | +149.0% | +22.4% |
| December 31, 2023 | $183.04M | +111.7% | +43.6% |
- STAAR SURGICAL CO showed an increase of +6.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, STAAR SURGICAL CO’s cash and equivalents has grown by 2967.9% (from $4.99 million to $153.15 million).
- The most recent figure is from STAAR SURGICAL CO’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: